USDA-APHIS Designates Additional Cibus’ Disease Resistance Trait Products as Not Regulated
Cibus, Inc. - Class A (CBUS)
Company Research
Source: GlobeNewswire
SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural technology company that develops and licenses plant traits to seed companies, announced today that two of its disease resistance trait products under development for canola have been designated as being not regulated by the United States Department of Agriculture’s Animal and Plant Health Inspection Service (USDA-APHIS) Biotechnology Regulatory Services (BRS). The two trait products reviewed by USDA-APHIS were developed utilizing Cibus’ Rapid Trait Development System™ (RTDS®) technologies that enable targeted genetic changes without integrating recombinant DNA – foreign genetic material – at any stage in the crop’s development. As a result of this designation, USDA-APHIS has confirmed the plants do not meet the definition of a “regulated article” under 7 CFR Part 340, which enables Cibus to proceed with product development without restrictions associated with regulated a
Show less
Read more
Impact Snapshot
Event Time:
CBUS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CBUS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CBUS alerts
High impacting Cibus, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
CBUS
News
- Cibus Welcomes the Positive Conclusion of Trilogue Negotiations on New Genomic Techniques Legislation Between the European Parliament and Council [Yahoo! Finance]Yahoo! Finance
- Cibus Welcomes the Positive Conclusion of Trilogue Negotiations on New Genomic Techniques Legislation Between the European Parliament and CouncilGlobeNewswire
- Cibus (NASDAQ:CBUS) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They now have a $15.00 price target on the stock.MarketBeat
- Earnings To Watch: Cibus Inc (CBUS) Reports Q3 2025 Result [Yahoo! Finance]Yahoo! Finance
- Cibus Announces the Election of Craig Wichner to Board of Directors [Yahoo! Finance]Yahoo! Finance
CBUS
Earnings
- 11/13/25 - Miss
CBUS
Analyst Actions
- 12/8/25 - Canaccord Genuity
CBUS
Sec Filings
- 11/25/25 - Form 4
- 11/25/25 - Form 3
- 11/10/25 - Form 8-K
- CBUS's page on the SEC website